LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

Начало・Списък с акции・Cytek Biosciences Inc

Cytek Biosciences Inc

Затворен

СекторЗдравеопазване

4.03 -1.47

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.95

Максимум

4.1

Ключови измерители
By Trading Economics
Приходи	25M -19M
Продажби	-18M 44M
EPS	-0.1
Марж на печалбата	-42.746
Служители	678
EBITDA	-15M -16M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+39.12% upside

Дивиденти
By Dow Jones
Следващи печалби	5.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-70M 532M
Предишно отваряне	5.5
Предишно затваряне	4.03

Настроения в новините

By Acuity

50%

161 / 344 Класиране в Healthcare

Cytek Biosciences Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.06.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Salesforce to Buy m3ter in Nod Toward AI-Native Business Models

8.06.2026 г., 15:41 ч. UTC

Значими двигатели на пазара

American Battery Shares Jump on Energy Department Victory

8.06.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rebound After Monday's Selloff -- Market Talk

8.06.2026 г., 23:37 ч. UTC

Пазарно говорене

Oil Edges Higher Amid Ongoing Supply Disruption Concerns -- Market Talk

8.06.2026 г., 23:25 ч. UTC

Пазарно говорене

Should Australia Consider State-Linked Commodities Export Desk? -- Market Talk

8.06.2026 г., 23:25 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.06.2026 г., 21:57 ч. UTC

Придобивния, сливания и поглъщания

Salesforce Expects to Close Deal in 2Q of Fiscal 2027

8.06.2026 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

Salesforce Agrees to Buy m3ter

8.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

8.06.2026 г., 19:22 ч. UTC

Пазарно говорене

Oil Settles Higher as Israel-Iran Exchanges Raise Tension -- Market Talk

8.06.2026 г., 19:01 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Pull Back on Weather Outlook -- Market Talk

8.06.2026 г., 18:52 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

8.06.2026 г., 18:52 ч. UTC

Пазарно говорене

CAD Needs Trade Deal to Trigger Sustained Rally -- Market Talk

8.06.2026 г., 18:17 ч. UTC

Пазарно говорене

Oil Pulls Back Further As Iran, Israel Put Strikes on Hold -- Market Talk

8.06.2026 г., 17:32 ч. UTC

Пазарно говорене

Bank of Canada Should Incorporate Unemployment Rate Into Its Forecast -- Market Talk

8.06.2026 г., 17:29 ч. UTC

Пазарно говорене

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8.06.2026 г., 17:29 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

8.06.2026 г., 16:55 ч. UTC

Придобивния, сливания и поглъщания

Monte dei Paschi: Mediobanca Integration Proceeding According to Plan

8.06.2026 г., 16:54 ч. UTC

Придобивния, сливания и поглъщания

Monte dei Paschi to Review Proposals From Banco BPM, Intesa Sanpaolo

8.06.2026 г., 16:40 ч. UTC

Пазарно говорене

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8.06.2026 г., 16:31 ч. UTC

Пазарно говорене

No Recession in Canada, Scotiabank's CEO Says -- Market Talk

8.06.2026 г., 16:27 ч. UTC

Пазарно говорене

Mexican Inflation Seen Easing in May -- Market Talk

8.06.2026 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

8.06.2026 г., 16:03 ч. UTC

Придобивния, сливания и поглъщания

Orange Bought Stake From Lorca

8.06.2026 г., 16:01 ч. UTC

Придобивния, сливания и поглъщания

Orange Completes Acquisition of Remaining 50% Stake in MasOrange

8.06.2026 г., 16:01 ч. UTC

Придобивния, сливания и поглъщания

Orange Acquires 100% Ownership of MasOrange

8.06.2026 г., 15:58 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.06.2026 г., 15:58 ч. UTC

Пазарно говорене

Gold Trims Losses After Israel, Iran Halt Exchanges of Fire -- Market Talk

8.06.2026 г., 15:55 ч. UTC

Пазарно говорене

Markets Price Small Chance USMCA Will Be Dismantled -- Market Talk

8.06.2026 г., 15:41 ч. UTC

Пазарно говорене

Gold Falls Below 200-Day Moving Average -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Cytek Biosciences Inc Прогноза

Ценова цел

By TipRanks

39.12% нагоре

12-месечна прогноза

Среден 5.69 USD 39.12%

Висок 7.5 USD

Нисък 4.75 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Cytek Biosciences Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Cytek Biosciences Inc през последните 3 месеца.

Настроение

By Acuity

161 / 344 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.